Home » Business, Health & Medicine, Manufacturing & Industry, Marketing & Sales, Pharmaceuticals & Biotech » Healthcare Cold Chain Market: Opportunities for Clinical Trial Materials
“Healthcare Cold Chain Logistics Market”
Driven by increasing outsourcing trends and rising spending on clinical trials involving biopharmaceutical products, the global clinical trials cold chain logistics market is expected to witness a healthy growth rate in the coming years

Catalysed by the globalization and increasing spending on clinical trials, the demand for efficient storage, packaging and transportation services for clinical trial materials has increased at a healthy growth rate over the past few years. Research firm IMARC Group expects this market to grow at a CAGR of around 4% during 2015-2020, according to its latest report titled “Global Healthcare Cold Chain Logistics Market Report & Forecast (2015-2020)”. According to an analyst at IMARC Group, “the increasing trends in clinical trials outsourcing is creating additional steps in the overall supply chain of clinical trial materials (drugs, blood samples, tissue samples, urine samples, sputum samples, etc). In many cases contract research organizations and their sponsors may be present in two different countries, which is quite evident from the fact that the number of clinical trials in many Asian, Latin American and East European countries are increasing rapidly whereas the sponsors are based in the US and Western Europe. This large distance is creating a huge requirement for the efficient cold chain packaging, storage and transportation of clinical trial materials between the clinical trial sponsor and the contract research organization.”

IMARC’s new report entitled “Global Healthcare Cold Chain Logistics Market Report & Forecast (2015-2020)”, which is the fourth edition of our highly acclaimed publication, provides a comprehensive insight into the logistic opportunities in the global healthcare market. This report can serve as an excellent guide for logistics service providers, equipment manufacturers, researchers, consultants, marketing strategists and all those who plan to foray into the healthcare cold chain logistics market in any form.

Key Questions Answered in This Report?

  • What are the current, historical and future market trends in the global healthcare cold chain logistics market?
  • What are the current, historical and future market trends in the global clinical trials cold chain logistics market?
  • What are the current, historical and future market trends in the global biopharmaceutical cold chain logistics market?
  • What are the current, historical and future market trends in the global vaccine cold chain logistics market?
  • What is the size of the global cold chain transportation logistics market?
  • What is the breakup of the global cold chain transportation logistics market?
  • What is the size of the global cold chain packaging logistics market?
  • What is the breakup of the global cold chain packaging  logistics market
  • What is the size of the global cold chain instrumentation logistics market?
  • What is the breakup of the global cold chain instrumentation logistics market?
  • What is the breakup of the global healthcare cold chain logistics market by region?
  • What are the various healthcare cold chain transportation methods?
  • What are the drivers and challenges in the global healthcare cold chain logistics market?
  • What are the opportunities in the global healthcare cold chain logistics market?

Table of Contents

1 Research Methodology & Market Definitions
2 Executive Summary
3 Current Trends in the Global Healthcare Cold Chain Logistic Services Market
3.1 Healthcare Cold Chain Products are Exhibiting Exponential Growth
3.2 Temperature Sensitive Healthcare Products Have Well Defined Logistic Needs
3.3 Outsourcing Trends in Research and Manufacturing Have Increased Logistic Demands
3.4 Increasing Regulatory Focus on the Integrity of Transported Healthcare Products
3.5 Cost is Not Always the Most Important Driver in Supplier Decisions
4 Healthcare Cold Chain Logistics: How Does It Operate?
4.1 Cold Chain Packaging and Transportation Methods
4.1.1 Dry Ice
4.1.2 Liquid Nitrogen
4.1.3 Gel Packs
4.2 Setting Up a Cold Chain
4.2.1 Initial Considerations
4.2.2 Choosing the Correct Model
4.2.3 Regulatory/Custom Clearance
4.2.4 Final Stages
4.2.5 Quality Assurance
4.1 Modeling the Cost of Cold Chain Packaging and Transportation
5 The Healthcare Cold Chain Logistic Services Market
5.1 Current Market Trends
5.2 Market Breakup by Product
5.2.1 Clinical Trial Materials
5.2.2 Vaccines
5.2.3 Biopharmaceuticals
5.3 Market Breakup by Segment
5.3.1 Transportation
5.3.1.1 Current and Historical Market Trends
5.3.1.2 Market Breakup by Transportation Type
5.3.1.3 Market Forecast
5.3.2 Packaging
5.3.2.1 Current and Historical Market Trends
5.3.2.2 Market Breakup by Packaging Type
5.3.2.3 Market Forecast
5.3.3 Instrumentation
5.3.3.1 Current and Historical Market Trends
5.3.3.1 Market Breakup by Instrumentation Type
5.3.3.1 Market Forecast
5.4 Market Breakup by Region
5.4.1 North America
5.4.2 Europe
5.4.3 Asia Pacific
5.4.4 Rest of the World
6 The Global Healthcare Cold Chain Products Market
6.1 Historical, Current and Future Market Trends
6.2 Market Segments
6.2.1 Biopharmaceuticals
6.2.1.1 Historical, Current and Future Market Trends
6.2.1.2 Cold Chain Requirements for Biopharmaceuticals
6.2.1.3 Cold Chain Opportunities for Biopharmaceuticals
6.2.2 Vaccines
6.2.2.1 Historical, Current and Future Market Trends
6.2.2.2 Cold Chain Requirements for Vaccines
6.2.2.3 Cold Chain Opportunities for Vaccines
6.2.3 Clinical Trial Materials
6.2.3.1 Historical, Current and Future Market Trends
6.2.3.2 Cold Chain Requirements for Clinical Trial Materials
6.2.3.3 Cold Chain Opportunities for Clinical Trial Materials
7 Challenges in the Healthcare Cold Chain Logistics Market
8 Global Trade of Temperature Sensitive Healthcare Products
8.1 Global Exports of Temperature Sensitive Healthcare Products
8.1.1 Current and Historical Trends
8.1.2 Major Exporting Countries
8.2 Global Imports of Temperature Sensitive Healthcare Products
8.2.1 Current and Historical Trends
8.2.2 Major Importing Countries
9 Key Company Profiles
9.1 World Courier
9.2 DHL
9.3 Fedex
9.4 United Parcel Service
9.5 Kuehne and Nagel
9.6 Cavalier Logistics
9.7 DB Schenker
9.8 Life ConEx
9.9 American Airlines Cargo
9.10 Continental Air Cargo
9.11 Marken

List of Figures

Figure 3 1: Global – Healthcare Cold & Non Cold Chain Products Market (in Billion US$), 2007 – 2014
Figure 3 2: Global – Healthcare Cold & Non Cold Chain Products Market Forecast (in Billion US$), 2015 – 2020
Figure 3 3: Global – Potency of the Tetanus Component of a DTP Vaccine Stored for 45 Days at Various Temperatures
Figure 3 4: Global – Contract Research & Manufacturing Market (in Billion US$), 2009 – 2014
Figure 3 5: Global – Contract Research & Manufacturing Market Forecast (in Billion US$), 2015 – 2020
Figure 3 6: Estimated Costs incurred in Various Pharmaceutical Operations
Figure 4 1: A Typical Drug Supply Chain from the Manufacturer to the End User
Figure 5 1: Global – Healthcare Cold Chain Logistic Services Market (in Billion US$), 2004 – 2014
Figure 5 2: Global – Healthcare Non Cold Chain Logistic Services Market (in Billion US$), 2004 – 2014
Figure 5 3: Global – Healthcare Logistic Services Market, Share of Cold-Chain and Non Cold-Chain Services*, (in %), 2014
Figure 5 4: Global – Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2015 – 2020
Figure 5 5: Global – Healthcare Non Cold Chain Logistic Services Market Forecast (in Billion US$), 2015 – 2020
Figure 5 6: Global – Healthcare Logistic Services Market Forecast, Share of Cold-Chain and Non Cold-Chain Services*, (in %), 2020
Figure 5 7: Global – Healthcare Cold Chain Logistic Services Market by Product (in %), 2014 and 2020
Figure 5 8: Global – Clinical Trial Materials Cold Chain Logistic Services Market (in Billion US$), 2004 – 2014
Figure 5 9: Global – Clinical Trial Materials Cold Chain Logistic Services Market Forecast (in Billion US$), 2015 – 2020
Figure 5 10: Global – Vaccines Cold Chain Logistic Services Market (in Billion US$), 2004 – 2014
Figure 5 11: Global – Vaccines Cold Chain Logistic Services Market Forecast (in Billion US$), 2015 – 2020
Figure 5 12: Global – Biopharmaceuticals Cold Chain Logistic Services Market (in Billion US$), 2004 – 2014
Figure 5 13: Global – Biopharmaceuticals Cold Chain Logistic Services Market Forecast (in Billion US$), 2015 – 2020
Figure 5 14: Global – Healthcare Cold Chain Logistic Services Market by Segment (in %), 2014 and 2020
Figure 5 15: Global – Healthcare Cold Chain Transportation Services Market (in Billion US$), 2004 – 2014
Figure 5 16: Global – Healthcare Cold Chain Transportation Services Market: Breakup by Transportation Mode (in %), 2014
Figure 5 17: Global – Healthcare Cold Chain Transportation Services Market Forecast (in Billion US$), 2015 – 2020
Figure 5 18: Global – Healthcare Cold Chain Packaging Services Market (in Billion US$), 2004 – 2014
Figure 5 19: Global – Healthcare Cold Chain Packaging Services Market: Breakup by Packaging Type (in %), 2014
Figure 5 20: Global – Healthcare Cold Chain Instrumentation Services Market Forecast (in Billion US$), 2015 – 2020
Figure 5 21: Global – Healthcare Cold Chain Instrumentation Services Market (in Billion US$), 2004 – 2014
Figure 5 22: Global – Healthcare Cold Chain Instrumentation Services Market: Breakup by Instrumentation Type (in %), 2014
Figure 5 23: Global – Healthcare Cold Chain Instrumentation Services Market Forecast (in Billion US$), 2015 – 2020
Figure 5 24: Global – Healthcare Cold Chain Logistic Spending by Region (in US$ Billion), 2012, 2014, 2016, 2018 and 2020
Figure 5 25: North America – Healthcare Cold Chain Logistic Services Market – (in Billion US$), 2008 – 2014
Figure 5 26: North America – Healthcare Cold Chain Logistic Services Market Forecast – (in Billion US$), 2015 – 2020
Figure 5 27: Europe – Healthcare Cold Chain Logistic Services Market (in Billion US$), 2008 – 2014
Figure 5 28: Europe – Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2015 – 2020
Figure 5 29: Asia Pacific – Healthcare Cold Chain Logistic Services Market (in Billion US$), 2008 – 2014
Figure 5 30: Asia Pacific – Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2015 – 2020
Figure 5 31: Rest of the World – Healthcare Cold Chain Logistic Services Market (in Billion US$), 2008 – 2014
Figure 5 32: Rest of the World – Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2015 – 2020
Figure 6 1: Global – Healthcare Cold Chain Products Market – Breakup by Segment (in %), 2007 – 2014
Figure 6 2: Global – Healthcare Cold Chain Products Market Forecast – Breakup by Segment (in %), 2015 – 2020
Figure 6 3: Global – Biopharmaceutical Market (in Billion US$), 2007 – 2014
Figure 6 4: Global – Biopharmaceutical Market Forecast (in Billion US$), 2015 – 2020
Figure 6 5: Global – Biosimilar Sales and Forecast (in Million US$), 2014 and 2020
Figure 6 6: Global – Share of Biopharmaceutical Manufacturers Outsourcing Some Production to Contract Manufacturers (in %), 2006 and 2011
Figure 6 7: Global – Biopharmaceutical Contract Manufacturing Market (in Billion US$), 2011 – 2014
Figure 6 8: Global – Biopharmaceutical Contract Manufacturing Market Forecast (in Billion US$), 2015 – 2020
Figure 6 9: Global – Vaccine Market (in Billion US$), 2007 – 2014
Figure 6 10: Global – Vaccine Market Forecast (in Billion US$), 2015 – 2020
Figure 6 11: Global – Vaccine Production Volume by Region (in %), 2008*
Figure 6 12: Europe – Vaccine Export Volume by Region (in %), 2008*
Figure 6 13: Global – Clinical Trials Market (in Billion US$), 2007 – 2014
Figure 6 14: Global – Clinical Trials Market – Spending on Biopharmaceuticals & Small Molecule Drugs (in Billion US$), 2009 – 2014
Figure 6 15: Time Taken for Biopharmaceuticals to Get Approved (in Months), 1982 – 2009
Figure 6 16: Global – Clinical Trials Market Forecast (in Billion US$), 2015 – 2020
Figure 6 17: Global – Clinical Trials Market Forecast – Spending on Biopharmaceuticals & Small Molecule Drugs (in Billion US$), 2015 – 2020
Figure 6 18: Number of Multinational Clinical Trials (Phase II and III) in Asian Countries by the Top Twenty Global Pharmaceutical Companies*
Figure 6 19: Global – Breakup of Biopharmaceuticals and Small Molecule Drugs in Preclinical & Clinical trials, (in %), 2009
Figure 6 20: Top Reasons for Conducting Clinical Trials in Each Country (in %), 2009
Figure 7 1: Financing Sources and Gaps (in %), 2008 – 2010
Figure 8 1: Global – Exports of Temperature Sensitive Healthcare Products: Vaccines for Human Use (in Tons), 2007-2013
Figure 8 2: Global – Exports of Temperature Sensitive Healthcare Products: Vaccines for Veterinary Use (in Tons), 2007 – 2013
Figure 8 3: Global – Exports of Temperature Sensitive Healthcare Products: Antisera and Other Blood Fractions, (in Tons), 2007 – 2013
Figure 8 4: Global – Exports of Temperature Sensitive Healthcare Products: Human Blood, Animal Blood for Therapeutic, Prophylactic/Diagnostics Uses and Microbial Preparations, (in Tons), 2007 – 2013
Figure 8 5: Global – Exports of Temperature Sensitive Healthcare Products: Insulin in Dosage (in Tons), 2007 – 2013
Figure 8 6 : Global – Exports of Temperature Sensitive Healthcare Products: Insulin Formulated in Bulk (in Tons), 2007 – 2013
Figure 8 7: Global – Exports of Temperature Sensitive Healthcare Products: Adrenal Cortex Hormones, in Dosage, (in Tons), 2007 – 2013
Figure 8 8: Global – Temperature Sensitive Healthcare Products: Vaccines for Human Use: Export Volume Breakup by Country (in %), 2013
Figure 8 9: Global – Temperature Sensitive Healthcare Products: Vaccines for Veterinary Use: Export Volume Breakup by Country (in %), 2013
Figure 8 10: Global – Temperature Sensitive Healthcare Products: Antisera and Other Blood Fractions: Export Volume Breakup by Country (in %), 2013
Figure 8 11 : Global – Temperature Sensitive Healthcare Products: Human Blood, Animal Blood for Therapeutic, Prophylactic/Diagnostics Uses and Microbial Preparations: Export Volume Breakup by Country (in %), 2013
Figure 8 12: Global – Temperature Sensitive Healthcare Products: Insulin in Dosage: Export Volume Breakup by Country (in %), 2013
Figure 8 13: Global – Temperature Sensitive Healthcare Products: Insulin Formulated in Bulk: Export Volume Breakup by Country (in %), 2013
Figure 8 14: Global – Temperature Sensitive Healthcare Products: Adrenal Cortex Hormones in Dosage: Export Volume Breakup by Country (in %), 2013
Figure 8 15: Global – Imports of Temperature Sensitive Healthcare Products: Vaccines for Human Use (in Tons), 2007 – 2013
Figure 8 16: Global – Imports of Temperature Sensitive Healthcare Products: Vaccines for Veterinary Use (in Tons), 2007 – 2013
Figure 8 17: Global – Imports of Temperature Sensitive Healthcare Products: Antisera and Other Blood Fractions, (in Tons), 2007 – 2013
Figure 8 18: Global – Imports of Temperature Sensitive Healthcare Products: Human Blood, Animal Blood for Therapeutic, Prophylactic/Diagnostics Uses and Microbial Preparations, (in Tons), 2007 – 2013
Figure 8 19 : Global – Imports of Temperature Sensitive Healthcare Products: Insulin in Dosage (in Tons), 2007 – 2013
Figure 8 20 : Global – Imports of Temperature Sensitive Healthcare Products: Insulin Formulated in Bulk (in Tons), 2007 – 2013
Figure 8 21: Global – Imports of Temperature Sensitive Healthcare Products: Adrenal Cortex Hormones, in Dosage, (in Tons), 2007 – 2013
Figure 8 22: Global – Temperature Sensitive Healthcare Products: Vaccines for Human Use: Import Volume Breakup by Country (in %), 2013
Figure 8 23: Global – Temperature Sensitive Healthcare Products: Vaccines for Veterinary Use: Import Volume Breakup by Country (in %), 2013
Figure 8 24: Global – Temperature Sensitive Healthcare Products: Antisera and Other Blood Fractions: Import Volume Breakup by Country (in %), 2013
Figure 8 25 : Global – Temperature Sensitive Healthcare Products: Human Blood, Animal Blood for Therapeutic, Prophylactic/Diagnostics Uses and Microbial Preparations: Import Volume Breakup by Country (in %), 2013
Figure 8 26: Global – Temperature Sensitive Healthcare Products: Insulin in Dosage: Import Volume Breakup by Country (in %), 2013
Figure 8 27: Global – Temperature Sensitive Healthcare Products: Insulin Formulated in Bulk: Import Volume Breakup by Country (in %), 2013
Figure 8 28: Global – Temperature Sensitive Healthcare Products: Adrenal Cortex Hormones in Dosage: Import Volume Breakup by Country (in %), 2013

List of Tables

Table 3 1: Various Regulations on Healthcare Cold Chain Logistic Requirements
Table 4 1: Average Amount of Dry Ice for Packaging Frozen Goods in a Single Well Insulated Container
Table 4 2: Dry Ice Containers
Table 4 3: Refrigerated Shipping Containers with Gel Packs
Table 4 4: Costs Associated With the Cold Chain Shipment of Healthcare Products, 2015*
Table 4 5: Costs Associated With the Non-Cold Chain Shipment of Healthcare Products, 2015
Table 5 1: Cold Chain Logistics: Comparison Matrix for Transport Modes
Table 6 1: Global – Healthcare Cold Chain Products Market – Breakup by Segment (in Billion US$), 2007 – 2014
Table 6 2: Global – Healthcare Cold Chain Products Market Forecast – Breakup by Segment (in Billion US$), 2015 – 2020
Table 6 3: Global – Biopharmaceutical Market – Sales by Class (in Billion US$), 2007 – 2014
Table 6 4: Global – Biopharmaceutical Market Forecast- Sales by Class (in Billion US$), 2015 – 2020
Table 6 5: Stability of Various Biopharmaceuticals at Room Temperature
Table 6 6: Complexity of the Manufacturing Process Involved with Biopharmaceuticals & Small Molecule Drugs
Table 6 7: Temperature Stability of Commonly Used Vaccines
Table 6 8: The Effect of Temperature Excursions on the Usability of Vaccines
Table 6 9: Global – Major Vaccine Production Sites (in Numbers), 2008*
Table 6 10: Ideal Storage Temperatures for Clinical Trial Materials
Table 7 1: Cold Chain & Logistic Funding Gaps Per Infant (in US$), 2008 – 2010

To buy the complete report or to get a free sample, please contact:

IMARC Group Asia:
Email: apac@imarcgroup.com
Phone: +91-120-415-5099 

IMARC Group North America:
Email: america@imarcgroup.com
Phone: +1-631-791-1145

IMARC Group Europe, Middle East & Africa:
Email: ema@imarcgroup.com
Phone: +44-702-409-7331 

To know more please visit: http://www.imarcgroup.com/healthcare-cold-chain-logistics-market

Media Contact
Company Name: IMARC Group
Contact Person: Krishna Sharma
Email: sales@imarcgroup.com
Phone: +91-120-415-5099
Address:G B Nagar Noida Complex
City: Noida
State: Uttar Pradesh
Country: India
Website: http://www.imarcgroup.com/

Comments are closed.